Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)
Hong Kong · Delayed Price · Currency is HKD 18.21
+0.08 (0.44%)
Sep 30, 2025, 4:08 PM HKT
HKG:0874 Market Cap
HKG:0874 has a market cap or net worth of 47.28 billion as of September 30, 2025. Its market cap has decreased by -3.17% in one year.
Market Cap
47.28B
Enterprise Value
44.08B
Revenue
83.04B
Ranking
n/a
PE Ratio
15.40
Stock Price
18.21
Market Cap Chart
Since February 6, 2001, HKG:0874's market cap has increased from 3.31B to 47.28B, an increase of 1,328.06%. That is a compound annual growth rate of 11.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 47.28B | -4.49% |
| Dec 31, 2024 | 49.51B | -8.44% |
| Dec 29, 2023 | 54.07B | -8.73% |
| Dec 30, 2022 | 59.24B | -24.54% |
| Dec 31, 2021 | 78.51B | 24.68% |
| Dec 31, 2020 | 62.97B | -9.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 279.26B |
| Hansoh Pharmaceutical Group Company | 210.92B |
| JD Health International | 206.50B |
| Innovent Biologics | 159.71B |
| WuXi Biologics | 158.73B |
| Sino Biopharmaceutical | 142.12B |
| Akeso | 124.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |